[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336583-105":59,"doc-detail-336583-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","egfr-her2-and-met-gene-amplification-and-protein-expression-profiles-in-biliary-tract-cancer-abstract-and-key-findings","EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer - Abstract and key findings","","Investigates EGFR, HER2, and MET receptor tyrosine kinase (RTK) alterations as potential biomarkers and therapeutic targets in biliary tract cancers, a rare, heterogeneous malignancy with limited conventional chemotherapy options. Immunohistochemistry was used to evaluate RTK protein overexpression in 193 tumor samples, while MET and HER2 gene amplification was assessed by silver in situ hybridization. MET/HER2 protein levels correlated with gene amplification and RTKs associated with adverse clinicopathologic features and shortened overall or recurrence-free survival, with worse outcomes for HER2 and EGFR double-positive cases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/egfr-her2-and-met-gene-amplification-and-protein-expression-profiles-in-biliary-tract-cancer-abstract-and-key-findings/336583/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/egfr-her2-and-met-gene-amplification-and-protein-expression-profiles-in-biliary-tract-cancer-abstract-and-key-findings/336583.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were RTK proteins and gene amplification assessed in biliary tract cancer samples?","Question",{"text":112,"@type":113},"RTK protein overexpression was evaluated by immunohistochemistry in 193 biliary tract cancer samples. MET and HER2 gene amplification was assessed using silver in situ hybridization.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What relationship was observed between MET/HER2 protein expression and gene amplification?",{"text":117,"@type":113},"MET and HER2 protein expressions were significantly correlated with their respective gene amplification status.",{"name":119,"@type":110,"acceptedAnswer":120},"Which RTK alterations were linked to prognosis in the study?",{"text":121,"@type":113},"Overall survival was significantly shorter in MET-amplified and EGFR-overexpressed cases, and recurrence-free survival correlated with HER2 amplification and EGFR overexpression. Patients double positive for HER2 and EGFR had shorter overall and recurrence-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336583,1790444257,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer and their prognostic significance  \nYeseul Kim1,, Seungyun Jee2, Hyunsung Kim3, Seung Sam Paik3, Dongho Choi4, Su Hyun Yoo5, Su-Jin Shin*,6,  \n1Department of Pathology, University of Korea College of Medicine, Anam Hospital, Seoul, Republic of Korea, 2Departments of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 3Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea,  \n4Department of Surgery, College of Medicine, Hanyang University, Seoul, Republic of Korea, 5Department of Pathology, National Police Hospital, Seoul, Republic of Korea,  \n6Departments of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea  \n* Corresponding author: Su-Jin Shin, MD, PhD, Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea ([charm@yuhs.ac](charm@yuhs.ac)) .  \nAbstract  \nBackground: There are limited conventional chemotherapy options for biliary tract cancers (BTCs), a heterogenous group of lethal, rare malignancies. The receptor tyrosine kinase (RTK) is closely associated with the progression of human malignancies through the regulation of cell cycle. Overexpression or amplification of RTKs has been investigated as a potential biomarker and therapeutic target in BTC; herein, we investigate the value of such interventions.  \nMaterials and Methods: Overexpression of RTK proteins was examined by immunohistochemistry in 193 BTC samples, of which 137 were gallbladder carcinoma, 29 were perihilar cholangiocarcinoma, and 27 were intrahepatic cholangiocarcinoma. Silver in situ hybridization of MET and HER2 was performed to assess gene amplification.  \nResults: In the entire cancer group, gallbladder, perihilar, and intrahepatic, MET amplification rates were 15.7%, 19.0%, 3.4%, and 14.8%, respectively, and of HER2 amplification rates were 22.4%, 27.2%, 17.2%, and 3.7%, respectively. MET and HER2 protein expressions were significantly correlated with their gene amplification status. RTKs were significantly associated with adverse clinicopathologic features such as advanced pT category and lymph node metastasis. Overall survival was significantly shorter in MET-amplified ( P = .024) and EGFR-overexpressed cases ( P = .045) . Recurrence-free survival was significantly correlated with HER2-amplified ( P = .038) and EGFR-overexpressed cases ( P = .046) in all patient groups. Overall and recurrence-free survival were significantly shorter in patients who were double positive for HER2 and EGFR. Conclusion: Our data suggested that MET, HER2, and EGFR might be potential therapeutic targets and that their co-expression is a strong prognostic factor for BTCs.  \nKey words: biliary tract cancer; gallbladder cancer; gene amplification; MET; HER2; EGFR.  \nReceived: 30 January 2024; Accepted: 3 April 2024.  \n© The Author(s) 2024. Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by-nc/4.0/](licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [reprints@oup.com](reprints@oup.com) for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [journals.permissions@oup.com](journals.permissions@oup.com).  \ne1052 The Oncologist, 2024, Vol. 29, No. 8  \nGraphical Abstract  \nImplications for practice  \nConventional chemotherapy for biliary tract cancers (BTCs), a","cbCaihfHYGZEMT9Z","https://ap.wps.com/l/cbCaihfHYGZEMT9Z","pdf",20634558,"English","# Abstract\n## Background\n## Materials and Methods\n## Results\n## Conclusion\n# Key words and publication details","[{\"question\":\"How were RTK proteins and gene amplification assessed in biliary tract cancer samples?\",\"answer\":\"RTK protein overexpression was evaluated by immunohistochemistry in 193 biliary tract cancer samples. MET and HER2 gene amplification was assessed using silver in situ hybridization.\"},{\"question\":\"What relationship was observed between MET/HER2 protein expression and gene amplification?\",\"answer\":\"MET and HER2 protein expressions were significantly correlated with their respective gene amplification status.\"},{\"question\":\"Which RTK alterations were linked to prognosis in the study?\",\"answer\":\"Overall survival was significantly shorter in MET-amplified and EGFR-overexpressed cases, and recurrence-free survival correlated with HER2 amplification and EGFR overexpression. Patients double positive for HER2 and EGFR had shorter overall and recurrence-free survival.\"}]","EGFR, HER2, and MET gene amplification and protein expression profiles in biliary tract cancer - Abstract and key findings | PDF",1790015724,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a11ad7ec887bed192ef4d1a869f1844b.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71dd1449093d5914f3f9f52354524cca.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2da717275f9e8eb6031b54af98bfe91c.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4778f074996298308ed3cdd73ebfba41.webp",980,1287]